Dwa oblicza selenu. Wybrane aspekty aktywności biologicznej selenu

• Autorzy: Golonko A. , Matejczyk M.

Warianty tytułu

EN

Two faces of selenium. Selected aspects of selenium biological activity

• Języki publikacji: PL

Abstrakty

PL

Badania ostatnich lat wskazują na bardzo cenne pod względem medycznym właściwości selenu. Zainteresowanie selenem wzrosło odkąd poznano metody jego oznaczania w materiale biologicznym i jego rolę w organizmach żywych. Selen w zależności od stężenia wykazuje właściwości antyoksydacyjne i prooksydacyjne. Ponadto w badaniach na zwierzętach oraz ludzkich i zwierzęcych liniach komórkowych wykazuje właściwości antynowotworowe. W dobie wzrostu zachorowalności na choroby nowotworowe, selen cieszy się dużym zainteresowaniem naukowców na całym świecie. Obecne wyniki badań wskazują na bardzo różnorodną aktywność biologiczną selenu. Jednym z głównych mechanizmów działania tego pierwiastka jest czynny udział w ochronie komórek przed skutkami stresu oksydacyjnego. W prezentowanej pracy przeglądowej omówiono ogólne właściwości selenu, zaprezentowano jego aktywność biologiczną i obecny stan wiedzy o jego potencjalnym działaniu antynowotworowym. Przedstawiono mechanizmy działania selenu na poziomie molekularnym.

EN

Studies of recent years indicate the very valuable properties of selenium in medical field. The interest in selenium has increased since we learned the methods of its determination in biological samples and its role in living organisms. Selenium, depending on the concentration, has antioxidant and prooxidative properties. In addition, in animal studies and human and animal cell lines, it exhibits anti-cancer properties. In the era of increased incidence of human and animal cancer, selenium is very popular among scientists around the world due to its high biological activity. Current research results highlight the various effects of selenium molecular activity. One of the main mechanisms of action of this element is active participation in the protection of cells against the effects of oxidative stress. The review presents the general properties of selenium, its biological activity and the current state of knowledge about its potential anticancer activity. Also, known molecular mechanisms of selenium activity in a living cell are mentioned.

Słowa kluczowe

PL

selen; aktywność biologiczna; działanie antynowotworowe

EN

selenium; biological activity; anti-cancer effect

• Wydawca: Oficyna Wydawnicza Politechniki Białostockiej
• Czasopismo: Budownictwo i Inżynieria Środowiska
• Rocznik: 2018
• Tom: Vol. 9, no. 2
• Strony: 65--74
• Opis fizyczny: Bibliogr. 96 poz., rys., tab.

Twórcy

autor

Golonko A.

• Wydział Budownictwa i Inżynierii Środowiska, Politechnika Białostocka, ul. Wiejska 45 A, 15-351 Białystok

autor

Matejczyk M.

• Wydział Budownictwa i Inżynierii Środowiska, Politechnika Białostocka, ul. Wiejska 45 A, 15-351 Białystok

Bibliografia

• Alatise O.I., Babalola O.O., Omoniyi-Esan G.O., Lawal O.O., Adesunkanmi A.R., Agbakwuru E.A. (2013). Selenium levels in neoplastic breast lesions. Nigerian PostgraduateMedical Journal, Vol. 20, No. 2, 91-97.
• Amaral A.F.S., Cantor K.P., Silverman D.T., Malats N. (2010). Selenium and Bladder Cancer Risk: a Meta-analysis. Cancer Epidemiology Biomarkers & Prevention, Vol. 19, No. 9, 2407-2415.
• Aribi M., Meziane W., Habi S., Boulatika Y., Marchandin H., Aymeric J.L. (2015). Macrophage bactericidal activities against Staphylococcus aureus are enhanced in vivo by selenium supplementation in a dose-dependent manner. edited by Lenz, L.L.PLoS ONE, Vol. 10, No. 9, e0135515.
• Babaknejad N., Sayehmiri F., Sayehmiri K., Rahimifar P., Bahrami S., Delpesheh A., Hemati F., et al. (2014). The relationship between selenium levels and breast cancer: A systematic review and meta-analysis. Biological Trace Element Research, Vol. 159, No. 1–3, 1-7.
• Di Bella S., Grilli E., Cataldo M.A., Petrosillo N. (2010). Selenium deficiency and HIV infection. Infectious Disease Reports, PAGEPress, Vol. 2, No. 2, 56-63.
• Benstoem C., Goetzenich A., Kraemer S., Borosch S., Manzanares W., Hardy G., Stoppe C. (2015). Selenium and its supplementation in cardiovascular disease – what do we know? Nutrients, Multidisciplinary Digital Publishing Institute (MDPI), Vol. 7 No. 5, 3094-3118.
• Berr C., Arnaud J., Akbaraly T.N. (2012). Selenium and cognitive impairment: A brief-review based on results from the EVA study. BioFactors, Vol. 38, No. 2, 139-144.
• Bi C.L., Wang H., Wang Y.J., Sun J., Dong J.S., Meng X., Li J.J. (2016). Selenium inhibits Staphylococcus aureusinduced inflammation by suppressing the activation of the NF-κB and MAPK signalling pathways in RAW264.7 macrophages. European Journal of Pharmacology, Vol. 780, 159-165.
• Biller-Takahashi J.D., Takahashi L.S., Mingatto F.E., Urbinati E.C. (2015). The immune system is limited by oxidative stress: Dietary selenium promotes optimal antioxidative status and greatest immune defense in pacu Piaractus mesopotamicus. Fish and Shellfish Immunology, Vol. 47, No. 1, 360-367.
• Brinkman M., Reulen R.C., Kellen E., Buntinx F., Zeegers M.P. (2006). Are men with low selenium levels at increased risk of prostate cancer? European Journal of Cancer, Vol. 42, No. 15, 2463-2471.
• Broome C.S., McArdle F., Kyle J.A.M., Andrews F., Lowe N.M., Hart C.A., Arthur J.R., et al. (2004). An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. American Journal of Clinical Nutrition, Vol. 80, No. 1, 154-162.
• Burk R.F., Hill K.E., Motley A.K. (2003). Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P.. The Journal of Nutrition, Vol. 133, No. 5, Suppl 1, 1517S-20S.
• Charalabopoulos K., Kotsalos A., Batistatou A., Charalabopoulos A., Vezyraki P., Peschos D., Kalfakakou V., et al. (2006). Selenium in serum and neoplastic tissue in breast cancer: Correlation with CEA. British Journal of Cancer, Vol. 95, No. 6, 674-676.
• Chen Y.-C., Prabhu K., Mastro A. (2013). Is Selenium a Potential Treatment for Cancer Metastasis? Nutrients, Multidisciplinary Digital Publishing Institute (MDPI), Vol. 5, No. 4, 1149-1168.
• Colpo E., Vilanova C.D.D.A., Brenner Reetz L.G., Medeiros Frescura Duarte M.M., Farias I.L.G., Irineu Muller E., Muller A.L.H., et al. (2013). A single consumption of high amounts of the Brazil nuts improves lipid profile of healthy volunteers. Journal of Nutrition and Metabolism, Hindawi, Vol. 2013.
• Cremonini E., Zonaro E., Donini M., Lampis S., Boaretti M., Dusi S., Melotti P., et al. (2016). Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts. Microbial Biotechnology, Vol. 9, No. 6, 758-771.
• Cui Z., Liu D., Liu C., Liu G. (2017). Serum selenium levels and prostate cancer risk: A MOOSE-compliant metaanalysis. Medicine, Wolters Kluwer Health, Vol. 96, No. 5, e5944.
• Cummins L.M., Kimura E.T. (1971). Safety evaluation of selenium sulfide antidandruff shampoos. Toxicology and Applied Pharmacology, Vol. 20, No. 1, 89-96.
• Dennert G., Zwahlen M., Brinkman M., Vinceti M., Zeegers M.P.A., Horneber M. (2012). Selenium for preventing cancer. in Dennert G. (Ed.), Sao Paulo Medical Journal, Vol. 130, John Wiley & Sons, Ltd, Chichester, UK, 67.
• Duncan A., Talwar D., McMillan D.C., Stefanowicz F., O’Reilly D.S.J. (2012). Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements. American Journal of Clinical Nutrition, Vol. 95, No. 1, 64-71.
• Ekoue D.N., Zaichick S., Valyi-Nagy K., Picklo M., Lacher C., Hoskins K., Warso M.A., et al. (2017). Selenium levels in human breast carcinoma tissue are associated with a common polymorphism in the gene for SELENOP (Selenoprotein P). Journal of Trace Elements in Medicine and Biology, Vol. 39, 227-233.
• Fan H., Kou J., Han D., Li P., Zhang D., Wu Q., He Q. (2015). Association between Vitamin C intake and the risk of pancreatic cancer: A meta-analysis of observational studies. Scientific Reports, Portland Press Ltd, Vol. 5, No. 5, 13973.
• Fernandes A.P., Gandin V. (2015). Selenium compounds as therapeutic agents in cancer. Biochimica et Biophysica Acta - General Subjects, Vol. 1850, No. 8,1642-1660.
• Gonzalez-Flores J.N., Shetty S.P., Dubey A., Copeland P.R. (2013). The molecular biology of selenocysteine. Biomolecular Concepts, NIH Public Access, Vol. 4, No. 4, 349-365.
• Hoffmann F.W., Hashimoto A.C., Shafer L.A., Dow S., Berry M.J., Hoffmann P.R. (2010). Dietary Selenium Modulates Activation and Differentiation of CD4+ T Cells in Mice through a Mechanism Involving Cellular Free Thiols. Journal of Nutrition, Vol. 140, No. 6, 1155-1161.
• Hoffmann P.R. (2007). Mechanisms by which selenium influences immune responses. Archivum Immunologiae et Therapiae Experimentalis, Birkhäuser-Verlag, Vol. 55, No. 5, 289-297.
• Hoffmann P.R., Berry M.J. (2008). The influence of selenium on immune responses. Molecular Nutrition and Food Research, NIH Public Access, Vol. 52, No. 11, 1273-1280.
• Hu H., Jiang C., Schuster T., Li G.-X., Daniel P.T., Lü J. (2006). Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Baxmediated activation of mitochondrial pathway. Molecular Cancer Therapeutics, Vol. 5, No. 7, 1873-1882.
• Hultqvist M., Olsson L.M., Gelderman K.A., Holmdahl R. (2009). The protective role of ROS in autoimmune disease. Trends in Immunology, Elsevier, Vol. 30, No. 5, 201-208.
• Jaffe W.G., Mondragon C. (1975). Effects of ingestion of organic selenium in adapted and non-adapted rats. The British Journal of Nutrition, Vol. 33, No. 3, 387-397.
• Jones G.D., Droz B., Greve P., Gottschalk P., Poffet D., McGrath S.P., Seneviratne S.I., et al. (2017). Selenium deficiency risk predicted to increase under future climate change. Proceedings of the National Academy of Sciences of the United States of America, National Academy of Sciences, Vol. 114, No. 11, 2848-2853.
• Jung H.J., Kim H.L., Kim Y.J., Weon J. Il, Seo Y.R. (2013). A novel chemopreventive mechanism of selenomethionine: Enhancement of APE1 enzyme activity via a Gadd45a, PCNA and APE1 protein complex that regulates p53-mediated base excision repair. Oncology Reports, Vol. 30, No. 4, 1581-1586.
• Khiralla G.M., El-Deeb B.A. (2015). Antimicrobial and antibiofilm effects of selenium nanoparticles on some foodborne pathogens. LWT - Food Science and Technology, Vol. 63, No. 2, 1001-1007.
• Kikkert J., Berkelaar E. (2013). Plant uptake and translocation of inorganic and organic forms of selenium. Archives of Environmental Contamination and Toxicology, Vol. 65, No. 3, 458-465.
• Kryscio R.J., Abner E.L., Caban-Holt A., Lovell M., Goodman P., Darke A.K., Yee M., et al. (2017). Association of antioxidant supplement use and dementia in the prevention of Alzheimer’s disease by Vitamin E and selenium trial (PREADViSE). JAMA Neurology, Vol. 74, No. 5, 567-573.
• Kuiper G.G.J.M., Kester M.H.A., Peeters R.P., Visser, T.J. (2005). Biochemical Mechanisms of Thyroid Hormone Deiodination. Thyroid, Vol. 15, No. 8, 787-798.
• Larsen P.R., Zavacki A.M. (2012). The role of the iodothyronine deiodinases in the physiology and pathophysiology of thyroid hormone action. European Thyroid Journal, Karger Publishers, Vol. 1, No. 4, 232-242.
• Lee S.-H., Almutairi S., Ali A.K. (2017). Reactive oxygen species modulate immune cell effector function. The Journal of Immunology, Vol. 198, No. 1 Supplement.
• Lee Y.K., Park S.Y., Kim Y.M., Kim D.C., Lee W.S., Surh Y.J., Park O.J. (2010). Suppression of mTOR via Akt-dependent and -independent mechanisms in seleniumtreated colon cancer cells: Involvement of AMPKα1. Carcinogenesis, Vol. 31, No. 6, 1092-1099.
• Lemire M., Philibert A., Fillion M., Passos C.J.S., Guimarães J.R.D., Barbosa F., Mergler D. (2012). No evidence of selenosis from a selenium-rich diet in the Brazilian Amazon. Environment International, Vol. 40, No. 1, 128-136.
• MacFarquhar J.K., Broussard D.L., Melstrom P., Hutchinson R., Wolkin A., Martin C., Burk R.F., i in. (2010a). Acute selenium toxicity associated with a dietary supplement. Archives of Internal Medicine, Vol. 170, No. 3, 256-261.
• MacFarquhar J.K., Broussard D.L., Melstrom P., Hutchinson R., Wolkin A., Martin C., Burk R.F., i in. (2010b). Acute selenium toxicity associated with a dietary supplement. Archives of Internal Medicine, NIH Public Access, Vol. 170, No. 3, 256-61.
• Medicine I. (2000). Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids : A Report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Inta. National Academy Press.
• Mehdi Y., Hornick J.L., Istasse L., Dufrasne I. (2013). Selenium in the environment, metabolism and involvement in body functions. Molecules, Vol. 18, No. 3, 3292-3311.
• Méplan C., Johnson I.T., Polley A.C.J., Cockell S., Bradburn D.M., Commane D.M., Arasaradnam R.P., i in. (2016)/ Transcriptomics and proteomics show that selenium affects inflammation, cytoskeleton, and cancer pathways in human rectal biopsies. FASEB Journal, Vol. 30, No. 8, 2812-2825.
• Michelle S., Steve W., Thomas W. (2016). Efficacy and mechanism of selenium nanoparticles as antibacterial agents. Frontiers in Bioengineering and Biotechnology, Vol. 4.
• de Miranda J.X., Andrade F. de O., Conti A. de, Dagli M.L.Z., Moreno F.S., Ong T.P. (2014). Effects of selenium compounds on proliferation and epigenetic marks of breast cancer cells. Journal of Trace Elements in Medicine and Biology, Vol. 28, No. 4, 486-491.
• Misra S., Boylan M., Selvam A., Spallholz J.E., Björnstedt M. (2015). Redox-active selenium compounds – from toxicity and cell death to cancer treatment. Nutrients, Multidisciplinary Digital Publishing Institute (MDPI), Vol. 7, No. 5, 3536-3556.
• Morris J.S., Crane S.B. (2013). Selenium toxicity from a misformulated dietary supplement, adverse health effects, and the temporal response in the nail biologic monitor. Nutrients, Multidisciplinary Digital Publishing Institute (MDPI), Vol. 5, No. 4, 1024-1057.
• Muecke R., Schomburg L., Glatzel M., Berndt-Skorka R., Baaske D., Reichl B., Buentzel J., et al. (2010). Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology. International Journal of Radiation Oncology Biology Physics, Vol. 78, No. 3, 828-835.
• Nilsonne, G., Sun, X., Nyström, C., Rundlöf, A.K., Potamitou Fernandes, A., Björnstedt, M. and Dobra, K. (2006), “Selenite induces apoptosis in sarcomatoid malignant mesothelioma cells through oxidative stress”, Free Radical Biology and Medicine, Vol. 41 No. 6, 874–885.
• Nuttall K.L. (2006). Evaluating selenium poisoning. Annals of Clinical and Laboratory Science, Vol. 36, No. 4, 409-420.
• de Oliveira Iglesias S., Leite H., Paes Â., de Oliveira S., Sarni R. (2014). Low plasma selenium concentrations in critically ill children: the interaction effect between inflammation and selenium deficiency. Critical Care, BioMed Central, Vol. 18, No. 3, R101.
• Olm E., Fernandes A.P., Hebert C., Rundlof A.-K., Larsen E.H., Danielsson O., Bjornstedt M. (2009). Extracellular thiolassisted selenium uptake dependent on the xc- cystine transporter explains the cancer-specific cytotoxicity of selenite. Proceedings of the National Academy of Sciences, Vol. 106, No. 27, 11400-11405.
• Outzen M., Tjønneland A., Larsen E.H., Friis S., Larsen S.B., Christensen J., Overvad K., et al. (2016). Selenium status and risk of prostate cancer in a Danish population. British Journal of Nutrition, Vol. 115, No. 9, 1669-1677.
• Painter E.P. (1941). The Chemistry and Toxicity of Selenium Compounds, with Special Reference to the Selenium Problem. Chemical Reviews, American Chemical Society, Vol. 28, No. 2, 179-213.
• Paplomata E., O’regan R. (2014). The PI3K/AKT/mTOR pathway in breast cancer: Targets, trials and biomarkers. Therapeutic Advances in Medical Oncology, SAGE Publications, Vol. 6, No. 4, 154-166.
• Park C.H., Kim Y.S., Kim Y.H., Choi M.Y., Yoo J.M., Kang S.S., Choi W.S., et al. (2008). Calcineurin mediates AKT dephosphorylation in the ischemic rat retina. Brain Research, Vol. 1234, 148-157.
• Park E.M., Choi K.S., Park S.Y., Kong E.S., Zu K., Wu Y., Zhang H., et al. (2005). A display thiol-proteomics approach to characterize global redox modification of proteins by selenium: Implications for the anticancer action of selenium. Cancer Genomics and Proteomics, Vol. 2, No. 1, 25-35.
• Porta C., Paglino C., Mosca A. (2014). Targeting PI3K/Akt/mTOR Signaling in Cancer. Frontiers in Oncology, Frontiers Media SA, Vol. 4, 64.
• Puspitasari I.M., Abdulah R., Yamazaki C., Kameo S., Nakano T., Koyama H. (2014). Updates on clinical studies of selenium supplementation in radiotherapy. Radiation Oncology, BioMed Central, Vol. 9, No. 1, 125.
• Rayman M.P. (2002). The argument for increasing selenium intake. Proceedings of the Nutrition Society, Vol. 61, No. 2, 203-215.
• Rayman M.P. (2012). Selenium and human health. The Lancet, Vol. 379, No. 9822, 1256-1268.
• Renko K., Hofmann P.J., Stoedter M., Hollenbach B., Behrends T., Köhrle J., Schweizer U., et al. (2009). Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice. The FASEB Journal, Vol. 23, No. 6, 1758-1765.
• De Rosa V., Erkekoǧlu P., Forestier A., Favier A., Hincal F., Diamond A.M., Douki T., et al. (2012). Low doses of selenium specifically stimulate the repair of oxidative DNA damage in LNCaP prostate cancer cells. Free Radical Research, Vol. 46, No. 2, 105-115.
• Sakr Y., Reinhart K., Bloos F., Marx G., Russwurm S., Bauer M., Brunkhorst F. (2007). Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure. British Journal of Anaesthesia, Vol. 98, No. 6, 775-784.
• Salimian J., Arefpour M.A., Riazipour M., Poursasan N. (2014). Immunomodulatory effects of selenium and vitamin e on alterations in T lymphocyte subsets induced by T-2 toxin. Immunopharmacology and Immunotoxicology, Vol. 36, No. 4, 275-281.
• Schomburg L. (2016). Dietary Selenium and Human Health. Nutrients, Multidisciplinary Digital Publishing Institute (MDPI), Vol. 9, No. 1, 22.
• Scientific Opinion on Dietary Reference Values for selenium (2014). EFSA Journal, Vol. 12 No. 10, 3846.
• Senthilkumaran S., Balamurugan N., Vohra R., Thirumalaikolundusubramanian P. (2012). Paradise Nut Paradox: Alopecia Due to Selenosis from a Nutritional Therapy. International Journal of Trichology, Wolters Kluwer - Medknow Publications, Vol. 4, No. 4, 283.
• Sharma V.K., McDonald T.J., Sohn M., Anquandah G.A.K., Pettine M., Zboril R. (2014). Biogeochemistry of selenium. A review. Environmental Chemistry Letters, Springer International Publishing, Vol. 13, No. 1, 49-58.
• Solovyev N.D. (2015). Importance of selenium and selenoprotein for brain function: From antioxidant protection to neuronal signalling. Journal of Inorganic Biochemistry, Vol. 153, 1-12.
• Son H., Lee S.M., Yoon R.G., Lee H., Lee I., Kim S., Chung W.Y., et al. (2017). Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer. Hellenic Journal of Nuclear Medicine, Vol. 20, No. 1, 62-70.
• Stefanowicz F.A., Talwar D., O’Reilly D.S.J., Dickinson N., Atkinson J., Hursthouse A.S., Rankin J., et al. (2013). Erythrocyte selenium concentration as a marker of selenium status. Clinical Nutrition, Vol. 32, No. 5, 837-842.
• Stephensen C.B., Marquis G.S., Douglas S.D., Kruzich L.A., Wilson C.M. (2007). Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults. American Journal Clinical Nutrition, Vol. 85, No. 1, 173-181.
• Stone C.A., Kawai K., Kupka R., Fawzi W.W. (2010). Role of selenium in HIV infection. Nutrition Reviews, Vol. 68, No. 11, 671-681.
• Suchocki P., Misiewicz I., Skupinska K., Waclawek K., Fijalek Z., Kasprzycka-Guttman T. (2007). The activity of Selol in multidrug-resistant and sensitive human leukemia cells. Oncology Reports, Vol. 18, No. 4, 893-899.
• Sun J.-W., Shu X.-O., Li H.-L., Zhang W., Gao J., Zhao L.-G., Zheng W., et al. (2016). Dietary selenium intake and mortality in two population-based cohort studies of 133 957 Chinese men and women. Public Health Nutrition, Vol. 19, No. 16, 2991-2998.
• Terry P.D., Qin B., Camacho F., Moorman P.G., Alberg A.J., Barnholtz-Sloan J.S., Bondy M., et al. (2017). Supplemental Selenium May Decrease Ovarian Cancer Risk in AfricanAmerican Women. The Journal of Nutrition, Vol. 147, No. 4, 621-627.
• Thompson P.A., Ashbeck E.L., Roe D.J., Fales L., Buckmeier J., Wang F., Bhattacharyya A., et al. (2016). Selenium supplementation for prevention of colorectal adenomas and risk of associated type 2 diabetes. Journal of the National Cancer Institute, Vol. 108, No. 12, 152.
• Thomson C.D. (2004). Assessment of requirements for selenium and adequacy of selenium status: A review. European Journal of Clinical Nutrition, Nature Publishing Group, Vol. 58, No. 3, 391-402.
• Tinggi U. (2008). Selenium: Its role as antioxidant in human health. Environmental Health and Preventive Medicine, Springer, Vol. 13, No. 2, 102-108.
• Tran P.A., Webster T.J. (2011). Selenium nanoparticles inhibit Staphylococcus aureus growth. International Journal of Nanomedicine, Dove Press, Vol. 6, 1553-1558.
• Tran P.L., Lowry N., Campbell T., Reid T.W., Webster D.R., Tobin E., Aslani A., et al. (2012). An organoselenium compound inhibits Staphylococcus aureus biofilms on hemodialysis catheters in vivo. Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Vol. 56, No. 2, 972-978.
• US Food and Drug Administration (2003). Labeling Nutrition - Qualified Health Claim: Final Decision Letter on Selenium and Certain Cancers (Docket No. 02P-0457). Center for Food Safety and Applied Nutrition.
• Vinceti M., Crespi C.M., Malagoli C., Del Giovane C., Krogh V. (2013). Friend or foe? The current epidemiologic evidence on selenium and human cancer risk. Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews, Taylor & Francis, Vol. 31, No. 4, 305-341
• Wallenberg M., Misra S., Björnstedt M. (2014). Selenium cytotoxicity in cancer. Basic and Clinical Pharmacology and Toxicology, Vol. 114, No. 5, 377-386.
• Whanger P.D. (2004). Selenium and its relationship to cancer: an update. British Journal of Nutrition, Vol. 91, No. 1, 11.
• White P.J. (2016). Selenium accumulation by plants. Annals of Botany, Vol. 117, No. 2, 217-235.
• Wilber C.G. (1980). Toxicology of selenium: A review. Clinical Toxicology, Taylor & Francis, Vol. 17, No. 2, 171-230.
• Wu Q., Rayman M.P., Lv H., Schomburg L., Cui B., Gao C., Chen P., et al. (2015). Low Population Selenium Status Is Associated With Increased Prevalence of Thyroid Disease. The Journal of Clinical Endocrinology & Metabolism, Vol. 100, No. 11, 4037-4047.
• Wu Y. (2006). Delineating the mechanism by which selenium deactivates Akt in prostate cancer cells. Molecular Cancer Therapeutics, Vol. 5, No. 2, 246-252.
• Xia R., Ganther H.E., Egge A., Abramson J.J. (2004). Selenium compounds modulate the calcium release channel/ryanodine receptor of rabbit skeletal muscle by oxidizing functional thiols. Biochemical Pharmacology, Vol. 67, No. 11, 2071-2079.
• Yip P.Y. (2015). Phosphatidylinositol 3-kinase-AKTmammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancer. Translational Lung Cancer Research, AME Publications, Vol. 4, No. 2, 165-176.
• Youn H.S., Ahn S.I., Lee B.Y. (2009). Guggulsterone suppresses the activation of transcription factor IRF3 induced by TLR3 or TLR4 agonists. International Immunopharmacology, Vol. 9, No. 1, 108-112.
• Zhuo H., Smith A.H., Steinmaus C. (2004). Selenium and lung cancer: A quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiology Biomarkers and Prevention, Vol. 13, No. 5, 771-778.

Uwagi

Opracowanie rekordu w ramach umowy 509/P-DUN/2018 ze środków MNiSW przeznaczonych na działalność upowszechniającą naukę (2019).